Biotechnology

Electric comb restores 98 percent of hair in mice

BUZZINGA team4 min read

Researchers led by China's Beihang University have developed an electric comb named Detangle that combines pulsed electric fields with two gene therapies, successfully restoring nearly 98% of lost hair in pattern-baldness mice within 28 days, outperforming minoxidil and finasteride drugs in animal trials.

The integration of graded electrode teeth with gene therapy in the Detangle comb opens an engineering horizon for delivering therapeutic molecules deep into hair follicles at nine times the rate of superficial methods, though results remain confined for now to laboratory mouse models.

Invention of the Detangle comb at Beihang University and study publication in Nature Communications

A research team led by scientists from Beihang University in China has successfully built an innovative electric comb named Detangle, designed to treat pattern hair loss by pairing pulsed electric fields with gene-based treatments. According to a scientific report by ScienceAlert on November 15, 2026, based on the research paper published in the journal Nature Communications, the device demonstrated notable superiority in mouse trials over common pharmaceutical treatments such as minoxidil and finasteride.

The new design aims to bypass the outer skin layer barrier that has long hindered large therapeutic molecules from reaching deep follicle cells without resorting to painful needle injections.

Restoration of 98% of hair within 28 days compared to 70% for minoxidil

Laboratory experiments on mice with pattern hair loss showed that combining the electric pulses emitted by the comb with two targeted gene therapies successfully restored approximately 98% of lost hair density in just 28 days.

For comparison within the same study, the group treated with traditional minoxidil recorded a recovery of about 70% of hair over the corresponding period. The comb operates through two complementary methods combining direct electrical stimulation of the scalp with the opening of precise temporary pathways allowing therapeutic genetic molecules to penetrate.

Engineering design of graded teeth and electric field propulsion to nine times the depth

The most prominent engineering innovation lies in designing the comb’s teeth with graded lengths and heights. The Nature Communications study explained that this graded arrangement pushes the electric field into hair follicles to a depth nine times greater than applying an electric field solely to the outer skin surface.

This targeted breakthrough allows dormant follicles to be stimulated and therapeutic compounds to be delivered directly to the targeted roots during simple brushing motions using an electronic circuit integrated within the comb’s handle.

Limits of animal models and human clinical trial requirements before medical use

Despite the striking figures recorded within a single month, scientific precision requires emphasizing that all these results were achieved in experiments conducted on laboratory mice, whose skin thickness, follicle growth cycle, and immune response differ from human scalps.

Therefore, the Detangle comb does not currently represent an approved medical product for human use, and moving from laboratory success to therapeutic application will require controlled clinical trials in humans to verify the safety of repeated electrical stimulation and the long-term safety of the accompanying gene therapies.

From the perspective of biomedical engineering and transdermal drug delivery, the Beihang University project highlights the potential of employing engineered pulsed electric fields to enhance the penetration of gene and molecular therapies without surgical procedures or repeated fine needles. However, the scientifically recognized gap between exceptional success in laboratory rodent models and achieving similar, safe results on the human scalp necessitates caution and avoiding premature research stages. Extended toxicity studies and documented human clinical trials will be the sole criteria for judging whether this experimental comb can be transformed into an approved therapeutic tool in the future.

Additionally, independent research teams will need to test the sustainability of regrown hair after stopping electrical stimulation sessions, study the response of various genetic and autoimmune baldness patterns in humans to ensure follicular cell safety and prevent long-term tissue side effects, and compare manufacturing costs and safe home-use ease against currently approved pharmaceutical protocols before making any commercial promises to patients worldwide.

Frequently asked questions

Question: What was the hair recovery percentage in the electric Detangle comb trials?
Answer: The combination of the comb’s electric pulses and two gene therapies restored about 98% of lost hair in mice within 28 days, compared to roughly 70% for minoxidil.

Question: What is the advantage of the graded-height comb teeth design?
Answer: The graded teeth allow the electric field to be pushed to a depth about nine times greater inside the hair follicles compared to surface application on the skin.

Question: Is this electric comb currently available for treating hair loss in humans?
Answer: No, the results published in Nature Communications were limited to mouse experiments, and the innovation still requires human clinical trials and regulatory approvals.